BDBM408592 US10358446, Compound 26
SMILES CC(C)Oc1cccc(Oc2ccc(cc2)-n2c3cnccc3n([C@@H]3CCN(C3)C(=O)C=C)c2=O)c1
InChI Key InChIKey=PQZFETCIWSCXDM-OAQYLSRUSA-N
Data 4 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 4 hits for monomerid = 408592
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Zibo Biopolar Changsheng Pharmaceutical
US Patent
Zibo Biopolar Changsheng Pharmaceutical
US Patent
Affinity DataIC50: <10nMAssay Description:Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase Lck(Homo sapiens (Human))
Zibo Biopolar Changsheng Pharmaceutical
US Patent
Zibo Biopolar Changsheng Pharmaceutical
US Patent
Affinity DataIC50: >1.00E+4nMAssay Description:Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase Lyn(Homo sapiens (Human))
Zibo Biopolar Changsheng Pharmaceutical
US Patent
Zibo Biopolar Changsheng Pharmaceutical
US Patent
Affinity DataIC50: 5.50E+3nMAssay Description:Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase Blk(Homo sapiens (Human))
Zibo Biopolar Changsheng Pharmaceutical
US Patent
Zibo Biopolar Changsheng Pharmaceutical
US Patent
Affinity DataIC50: 550nMAssay Description:Btk kinase activity was determined using a homogenous time resolved fluorescence (HTRF) methodology. Measurements were performed in a reaction volume...More data for this Ligand-Target Pair